Literature DB >> 3511686

Drug-drug and drug-disease interactions with nonsteroidal anti-inflammatory drugs.

D C Brater.   

Abstract

Nonsteroidal anti-inflammatory drugs may cause a number of drug interactions. They can displace other drugs from serum proteins, and some can affect the metabolism or decrease the renal elimination of other drugs. In addition, they can attenuate the pharmacologic effect of other drugs, such as diuretic and antihypertensive agents, without affecting their disposition. Lastly, many disease states and aging can affect the handling of nonsteroidal anti-inflammatory drugs, mandating dose adjustment of some of these agents in certain clinical conditions. Some drugs may require more of these adjustments than others.

Mesh:

Substances:

Year:  1986        PMID: 3511686     DOI: 10.1016/0002-9343(86)90933-2

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  16 in total

Review 1.  Choosing the right nonsteroidal anti-inflammatory drug for the right patient: a pharmacokinetic approach.

Authors:  N M Davies; N M Skjodt
Journal:  Clin Pharmacokinet       Date:  2000-05       Impact factor: 6.447

2.  Steady state pharmacokinetic profile of indomethacin in elderly patients and young volunteers.

Authors:  J C McElnay; A P Passmore; V L Crawford; J G McConnell; I C Taylor; F S Walker
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 3.  A comparison of synovial fluid concentrations of non-steroidal anti-inflammatory drugs with their in vitro activity.

Authors:  E Urquhart
Journal:  Agents Actions       Date:  1991-03

4.  Effect of tenidap sodium on the pharmacodynamics and plasma protein binding of warfarin in healthy volunteers.

Authors:  G Apseloff; K D Wilner; N Gerber
Journal:  Br J Clin Pharmacol       Date:  1995       Impact factor: 4.335

Review 5.  Pharmacokinetic drug interactions with nonsteroidal anti-inflammatory drugs.

Authors:  R K Verbeeck
Journal:  Clin Pharmacokinet       Date:  1990-07       Impact factor: 6.447

6.  Influence of meloxicam on furosemide pharmacokinetics and pharmacodynamics in healthy volunteers.

Authors:  F O Müller; R Schall; A C de Vaal; G Groenewoud; H K Hundt; M V Middle
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

Review 7.  Switching drug availability from prescription only to over-the-counter status. Are elderly patients at increased risk?

Authors:  S I Benrimoj; J H Langford; M G Bowden; E J Triggs
Journal:  Drugs Aging       Date:  1995-10       Impact factor: 3.923

Review 8.  The anti-inflammatory non-antibiotic helper compound diclofenac: an antibacterial drug target.

Authors:  K Mazumdar; S G Dastidar; J H Park; N K Dutta
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-04-28       Impact factor: 3.267

9.  The effects of naproxen and sulindac on renal function and their interaction with hydrochlorothiazide and piretanide in man.

Authors:  J J Dixey; F H Noormohamed; A F Lant; D A Brewerton
Journal:  Br J Clin Pharmacol       Date:  1987-01       Impact factor: 4.335

10.  Renal effects of nimesulide in furosemide-treated subjects.

Authors:  F Steinhäuslin; A Munafo; T Buclin; A Macciocchi; J Biollaz
Journal:  Drugs       Date:  1993       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.